Roche's inavolisib combination reduces the risk of disease progression by 57% in ... - Yahoo Finance

Retrieved on: 2023-12-08 22:22:09

Tags for this article:

Click the tags to see associated articles and topics

Roche's inavolisib combination reduces the risk of disease progression by 57% in ... - Yahoo Finance. View article details on hiswai:

Excerpt

... Antonio Breast Cancer Symposium and shared with health authorities Basel, 8 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presente.

Article found on: finance.yahoo.com